Evinature
Clinically proven, evidence-based nutraceuticals for gut health tailored to IBD, IBS, diverticulitis
Startup Seed Health Tech & Life Sciences Est. 2021
Total Raised
$6.5M
Seed
Last Round
$2.5M
3 rounds
Investors
1
1 public
Team
18
11-50 employees
Confidence
94/100
News
38
articles
Patents
1
About
Evinature was founded on the nexus of two medical philosophies. By bridging the gap between modern and traditional medicine, we’re able to provide more patients with safe and natural remedies that are embraced by the medical community. We believe it’s time for healthcare to prioritize patient global accessibility to accurate medical assessments and affordable treatments. No patents, no trends, no misinformation. We simply develop, test, prove, then give back to the community. Tailored Protocols: No two bodies are the same, which is why we provide evidence-based protocols that address each patient’s condition and state of severity so we can precisely target your individual needs and improve long-term results. Guided Care: Regular online follow-ups enable precise adjustments to your protocol so we can address your changing needs throughout treatment. And to ease the way, we also provide complementary clinic support to guide you through the entire process. Labs: We’re constantly refining our products through ongoing research and collaborations with over 20 leading medical centers in the U.S, enabling the further development of effective neutraceuticals that are accessible to patients worldwide. Evidence: Evinature prioritizes evidence above the trends. We are caregivers by profession, and therefore emphasize product quality and scientific integrity above all else, exclusively distributing products that have passed the golden standard of clinical trials. By the Patient for the Patient: Patients are the greatest untapped resource in healthcare, which is why we’ve developed a research database founded on their invaluable experience. At Evinature, each patient contributes to the community simply by taking the assessment. This allows us to constantly expand our research and keep the community updated with vital news and information.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Core Technology
BiologicalsHerbals
Target Customer
Healthcare & Life SciencesHealthcarePatients
Business Model
B2BB2B2CB2C
Tags
supplementsmedical-productsmental-healthpharmaceuticalsgastroenterologytreatmentsinflammatory-diseasescrohn's-diseasenutraceuticals
News (38)
May 12, 2025 · evinature.com
growth-positive
New CurQD Research Makes Waves at USA's Largest GI Conference | Evinature
Product StagePartners
Feb 19, 2025 · evinature.com
CurQD Protocol by Evinature Highlighted at Crohn’s & Colitis Congress 2025
Feb 9, 2025 · evinature.com
growth-positive
Tal’s Journey: Overcoming 16 Years of IBD - evinature
Product Stage
Feb 6, 2025 · evinature.com
growth-positive
Evinature Co-Founder Dr. Prof. Shomron Ben Horin, MD Presents Groundbreaking CurQD® Research at GEDII Conference in Portugal
Jan 29, 2025 · evinature.com
growth-positive
Lucy’s Journey to Remission: How CurQD Transformed Her Life - evinature
Jan 22, 2025 · evinature.com
growth-positive
Evinature Co-Founder Nir Salomon, ChB, Shares Insights in Live Interview with Leading IBD Advocate
Product StageCustomers
Dec 24, 2024 · evinature.com
Evinature Takes Center Stage at AIBD Conference
Nov 26, 2024 · evinature.com
growth-positive
CurQD by Evinature Found to Ease Life-Altering IBD Symptom
Customers
Nov 21, 2024 · evinature.com
growth-positive
Evinature's CurQD Successful in Pediatric Trial
Sep 27, 2024 · www.frontiersin.org
growth-positive
The efficacy of CurQD in children with active ulcerative colitis: a multicenter retrospective cohort study
Aug 28, 2024 · thesanfranciscotribune.com
growth-positive
6 Companies Making Waves in Modern Innovation
Aug 27, 2024 · worldfinancialreview.com
growth-positive
These are the 5 Next-Gen Startups Disrupting Their Industries - The World Financial Review
Jul 29, 2024 · ritzherald.com
growth-positive
6 Companies That Are Redefining Their Markets
CustomersPartnersInvestmentAcquisitionPublic TradingManagement ChangesLayoffsExpand
N/A
Evinature listed top among most-watched Health Tech companies in Startup Nation's H1 2024 Israeli Tech Report
N/A
growth-positive
Meet The Research Team That Broke The Therapeutic Ceiling In IBD  - Healthcare Business Today
CustomersPartners
May 9, 2024 · www.biopharmadive.com
growth-positive
Breaking Boundaries in IBD: Evinature's CurQD® Trial Spotlighted at the CCF’s IBD Innovate Conference 2024 | BioPharma Dive
PartnersCustomers
Apr 18, 2024 · ritzherald.com
growth-positive
Meet the Frontmen of Evinature, the Startup That’s Revolutionizing IBD Care | The Ritz Herald
CustomersExpand
Apr 8, 2024 · www.digitaljournal.com
growth-positive
Healthcare startup Evinature is now integrated across 35 US medical centres to further streamline IBD treatment accessibility - Digital Journal
CustomersPartners
Feb 19, 2024 · womensjournal.com
growth-positive
Evinature: Pioneering Integrative Therapies for IBD with the CurQD® Protocol - Women's Journal
CustomersExpand
Growth-Positive
Harvard Medical Professor Ashwin Ananthakrishnan Commends Evinature’s CurQD® Trial in CGH Editorial - The European Business Review
CustomersPartners
+ 18 more articles
Details
Product Stage
Released
Employees
11-50
Exact Count
17
Founded
2021
Registrar
516384070
Locations
HaMelacha St 3, Binyamina-Giv'at Ada, Israel
Links
Website
LinkedIn
Twitter
Facebook
Admin
Last Update
May 15, 2025
Verified by
Yanina Wainscheinker
Claimed
Yes
Missing
markets, not claimed
Team (18)
Apan Amos Damri
Founder, CEO
Founder
Dr. Prof. Shomron Ben-Horin M.D.
Founder, Chief Medical Officer
Founder
Nir Salomon ChB
Founder, Head of R&D
Founder
Shiri Mazor
Chief Operations Officer
Roi Ben Haim
Chief Technology Officer
Ella Lorentz
Vice President of Operations
Shirli Tehar Lev
Head of Customer Success
Idan Glaser
User Acquisition Manager
Kathryn Johnston-Avrahami
Clinic Support
Emma Grill
Clinic Support
Eliezra Oren
Clinic Support
Summer Pitocchelli
Content Writer
Dr. Prof. David T. Rubin M.D.
Medical Advisor
Rotem Sigall Boneh R.D.
Medical Advisor
William D. Chey M.D.
Medical Advisor
Dana Eden Shhori
Office Manager
Ofri Raif Dali
Product Manager
Jonathan Schwartzman
Senior Marketing Manager
Internal
Created by
Jonathan Schwartzman (jonathan@evinature.com)
Created
2022-11-29T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)